Healthcare -
Biotechnology - NASDAQ - US
$ 38.69
2.76 %
$ 10.8 B
Market Cap
21.98
P/E
EXEL - CASH & EQUIVALENTS
Cash & Equivalents EXEL - Exelixis, Inc.
217 M
LAST VALUE
-34.14%
2 YEAR CAGR
-3.99%
5 YEAR CAGR
10.46%
10 YEAR CAGR